Bibliography
- Costantini M, Ripamonti C, Beccaro M, et al. Prevalence, distress, management and relief of pain during the last three months of cancer patients’ life. Results of an Italian mortality follow-back survey. Ann Oncol 2009;20:729-35
- Breivik H, Cherny N, Collett F, et al. Cancer-related pain: a pan European survey of prevalence, treatment, and patient attitudes. Ann Oncol 2009;20:1420-33
- World Health Organization. Cancer pain relief. World Health Organization; Geneva: 1986
- World Health Organization. Cancer pain relief. 2nd edition. World Health Organization; Geneva: 1996
- Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA 1995;274(23):1870-3
- Ripamonti CI, Bandieri E, Roila F; On behalf of the ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 2011;22(Suppl 6):vi69-77
- Eisenberg E, Berkey C, Carr DB, et al. Efficacy and safety of nonsteroidal antinflammatory drugs for cancer pain: a meta-analysis. J Clin Oncol 1994;12:2756-65
- Kahan M, Mailis-Gagnon A, Wilson L, et al. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population. Can Fam Physician 2011;57(11):1257-66; e1407-1218
- Portenoy RK, Ahmed E. Principles of opioid use in cancer pain. J Clin Oncol 2014;16:1662-70
- Cherny N, Ripamonti C, Pereira J, et al. Expert Working Group of the European Association of Palliative Care Network. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001;19:2542-54
- Mercadante S, Bruera E. Opioid switching: a systematic and critical review. Cancer Treat Rev 2006;32:304-15
- Caraceni A, Hanks G, Kaasa S, European Palliative Care Research Collaborative (EPCRC); European Association for Palliative Care (EAPC). Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012;13(2):e58-68
- Gatti A, Casali M, Lazzari M, et al. Prolonged-release oxycodone/naloxone in nonmalignant pain: single-center study in patients with constipation. Adv Ther 2013;30(1):41-59
- Chou R. What we still don’t know about treating chronic noncancer pain with opioids. CMAJ 2010;182(9):881-2
- Jonsson T, Christrup LL, Hojsted J, et al. Symptoms and side effects in chronic non-cancer pain: patient report vs. systematic assessment. Acta Anaesthesiol Scand 2011;55(1):69-74
- Davies AN, Dickman A, Reid C, et al. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 2009;13(4):331-8
- Mercadante S. Pharmacotherapy for breakthrough cancer pain. Drugs 2012;72:181-90
- Pain therapy: fans in Italy are 4 times more expensive than opioids. Available from: http://www.fondazioneisal.it/en/pubblicazioni/weblog/178-cura-del-dolore-in-italia-la-spesa-per-i-fans-e-4- volte-quella-per-gli-oppiacei.html [Accessed 5 August 2014]
- Nekolaichuk C, Fainsinger RL, Lawlor P. Challenges of conducting research on cancer pain classification: how do we make sense of the outcomes? J Palliat Med 2013;16(11):1323-5
- Kramer M. Placebo run-in for antidepressant trials. Neuropsychopharmacology 1996;15(1):105-7
- Powers JH, Fleming TR. Noninferiority trials: clinical understandings and misunderstandings. Clin Investig 2013;3(3):215-18
- Glajchen M. Chronic pain: treatment barriers and strategies for clinical practice. J Am Board Fam Pract 2001;14(3):211-18
- Nabal M, Librada S, Redondo MJ, et al. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature. Palliat Med 2012;26:305